Key Moment For Gold-Silver Ratio

Key Moment For Gold-Silver Ratio

I have had a target on the gold-silver ratio of low 80’s to 90.  Then on Friday the GSR did this, putting that target in question (it hit 81, but I was thinking higher). Here it is today, converted to GLD-SLV… The weekly view is not broken down, however… Here’s the view of silver vs. […]
Miners Might Get DUSTed

Miners Might Get DUSTed

Miners have had a terrific lift since September 30, a 12% ascent in just four sessions. I would respectfully point you to the DUST graph, however (the triple-bearish-on-miners ETF) which is looking like it might be ready for a bounce. Adjunct to this, GLD is looking like it’s losing steam.
Are Bonds A Good Investment For You?

Are Bonds A Good Investment For You?

Bonds are a very popular investment, but before you buy any, let me tell you what I share with my clients about them. Think of a bond as a loan between you and a company or government. Assuming all goes normally, here’s how it looks: 1. You lend them a sum of money 2. They […]
More Signs Of Slower U.S. Growth In Today’s Economic Updates

More Signs Of Slower U.S. Growth In Today’s Economic Updates

Today’s updates on sentiment in the US services sector and the Federal Reserve’s Labor Market Conditions Index (LMCI) offer more evidence for arguing that economic growth is slowing in the third quarter. There’s still a solid pace of output in services, but LMCI confirms the weakening trend that’s conspicuous in Friday’s disappointing release on payrolls for September. […]
Thoughts From The Frontline: Recession Watch

Thoughts From The Frontline: Recession Watch

“Growth is never by mere chance; it is the result of forces working together.” – J.C. Penney “Strength and growth come only through continuous effort and struggle.” – Napoleon Hill “We’re lost, but we’re making good time.” – Yogi Berra, 1925-2015, RIP (For a most moving and memory-laden tribute to Yogi, see The Lefsetz Letter.) The Yogi Berra […]
Thoughts On Nuclear Energy

Thoughts On Nuclear Energy

I have a long technical article that I plan to study and improve when I am invited to visit the Stockholm School of Economics for the purpose of giving the kind of brilliant lecture on nuclear energy and nuclear economics that they both need and deserve. Whether the algebra involved is digested by my audience […]
5 Stocks To Watch This Week – October 5, 2015

5 Stocks To Watch This Week – October 5, 2015

(Photo Credit: Nicole Yeary) This week marks the beginning of the third quarter earnings season and expectations leave much to be desired. According to Estimize data, the S&P 500 is anticipated to post negative YoY EPS growth of 2.2%, with revenues pegged to come in at -1.7%. As always, it is still early, and estimates will […]
IBM Announces Carbon Nanotube Research Breakthrough: Why It’s A Big Deal

IBM Announces Carbon Nanotube Research Breakthrough: Why It’s A Big Deal

IBM announced a research breakthrough in carbon nanotube electronics for post-silicon electronics. Carbon nanotubes are one of the most promising replacements for silicon and could keep electronics and computing on Moore’s Law. IBM needs new computer systems that stay on Moore’s Law of exponentially increasing performance to support its push to next-generation applications. The research […]
US Session Bullet Report – USD Mixed But Gold Remains Strong

US Session Bullet Report – USD Mixed But Gold Remains Strong

US Session Bullet Report The EUR did not manage to advance further despite early indications that USD was under pressure. The pair was sold off at 1.1280 area and is trading just shy of 1.12 now. On the contrary GBPUSD is trading at session lows (1.5160) following disappointing PMI numbers. The BoE meets on Thursday […]
Aclaris Could Be A Sleeper

Aclaris Could Be A Sleeper

At first Aclaris [Nasdaq: ACRS] didn’t catch my eye. The phrase “concentrated hydrogen peroxide” sounded too simple to offer any sustainable competitive advantage. However a favorable mention from the famous “Dr. KSS” who knows his biotechnology made me take a closer look. What I see is a fairly low-risk to treat a very common skin condition (Seborrheic […]